newsfilter
← Latest News
Business Wire·

Adicet Bio, Inc. Announces $80 Million Registered Direct Offering

Adicet Bio, Inc. ("Adicet") (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the pricing of an